Related Experiment Video

Updated: Jun 4, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Hemoglobin A1c as a predictor of incident diabetes

Peiyao Cheng1, Britta Neugaard, Philip Foulis

  • 1Department of Veterans Affairs Medical Center, Tampa, Florida, USA.

Diabetes Care
|February 4, 2011
PubMed

Insights

Glycated hemoglobin (HbA1c) levels at 5.0% or higher significantly predict future diabetes diagnosis. Higher HbA1c values, especially 6.0-6.4%, indicate substantially increased diabetes risk.

Area of Science:

  • Endocrinology
  • Diabetes Mellitus Research
  • Clinical Diagnostics

Background:

  • Recent guidelines expand the use of glycated hemoglobin (HbA1c) for diagnosing diabetes.
  • Many individuals with HbA1c below the diagnostic threshold require risk stratification for future diabetes.
  • Predictive markers for incident diabetes are crucial for early intervention.

Purpose of the Study:

  • To evaluate the predictive ability of HbA1c levels for the incidence of a diabetes diagnosis.
  • To assess the risk associated with specific HbA1c ranges below the diagnostic threshold.

Main Methods:

  • A historical cohort study was conducted using electronic medical records from two VA Medical Centers.
  • 12,589 patients with baseline HbA1c <6.5% and no prior diabetes diagnosis were tracked for 8 years.
  • Follow-up data from 12,375 patients were analyzed for subsequent diabetes diagnosis.

Main Results:

  • Over an average follow-up of 4.4 years, 26.9% of patients developed diabetes.
  • HbA1c levels of 5.0% or higher were significantly associated with increased diabetes risk.
  • Adjusted odds ratios increased substantially with rising HbA1c levels: 1.70 (5.0-5.4%), 4.87 (5.5-5.9%), and 16.06 (6.0-6.4%) compared to <4.5%.

Conclusions:

  • Diabetes incidence progressively and significantly increases in patients with HbA1c ≥ 5.0%.
  • Patients with HbA1c levels between 6.0-6.4% face a substantially expanded risk of developing diabetes.
  • A validated risk model incorporating HbA1c, age, BMI, and systolic blood pressure can predict 5-year incident diabetes risk.
Abstract

More Related Videos

Electrochemiluminescence Assays for Human Islet Autoantibodies09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...